— Know what they know.
Not Investment Advice
Also trades as: 0LB2.L (LSE) · $vol 0M

SUPN NASDAQ

Supernus Pharmaceuticals, Inc.
1W: -3.5% 1M: -1.8% 3M: -2.9% YTD: -0.2% 1Y: +48.7% 3Y: +40.4% 5Y: +61.7%
$48.21
-1.17 (-2.37%)
 
Weekly Expected Move ±5.0%
$44 $47 $49 $52 $54
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Alpha Radar Neutral · Power 43 · $2.8B mcap · 54M float · 1.32% daily turnover · Short 40% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NARROW EDGE
57.9 / 100
NoneWeakNarrowWide
Primary source: Switching Costs  ·  ROIC: -4.1%  ·  5Y Avg: 3.1%
Cost Advantage
53
Intangibles
63
Switching Cost
65
Network Effect
52
Scale
50
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. SUPN has a Narrow competitive edge (57.9/100) — meaningful but not impregnable advantages over competitors. The primary source of advantage is Switching Costs. Negative ROIC of -4.1% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$0
Low
$65
Avg Target
$65
High
Based on 6 analyst ratings (12 mo)
Analyst Recommendations
Strong Buy: 0Buy: 9Hold: 5Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$65.00
Analysts1
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-02-25 Craig-Hallum Initiated $65 +12.9% $57.58
2025-12-19 Stifel Nicolaus Annabel Samimy $38 $55 +17 +11.6% $49.28
2025-10-08 Piper Sandler $40 $65 +25 +35.4% $48.00
2025-09-30 Cantor Fitzgerald $42 $63 +21 +32.9% $47.41
2025-08-29 Piper Sandler $36 $40 +4 -11.3% $45.12
2025-07-29 Cantor Fitzgerald Initiated $42 +25.6% $33.45
2024-09-11 Piper Sandler David Amsellem $41 $36 -5 +7.5% $33.49
2024-05-24 Piper Sandler David Amsellem Initiated $41 +47.2% $27.84
2024-04-08 Jefferies Irene Buhalo Initiated $40 +24.0% $32.27
2024-04-08 Stifel Nicolaus Annabel Samimy Initiated $38 +17.8% $32.27

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C+
May 22, 2026
DCF
5
ROE
1
ROA
1
D/E
3
P/E
1
P/B
2
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. SUPN receives an overall rating of C+. Strongest factors: DCF (5/5). Areas of concern: ROE (1/5), ROA (1/5), P/E (1/5), P/B (2/5).
Rating Change History
DateFromTo
2026-05-18 B- C+
2026-05-05 C+ B-
2026-04-01 B- C+
2026-03-31 B B-
2026-03-16 B- B
2026-03-12 B B-
2026-03-09 B- B
2026-03-02 B B-
2026-02-26 B- B
2026-01-15 B B-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

43 Grade D
Profitability
20
Balance Sheet
89
Earnings Quality
42
Growth
46
Value
30
Momentum
45
Safety
100
Cash Flow
50
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. SUPN scores highest in Safety (100/100) and lowest in Profitability (20/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
5.74
Safe Zone
Piotroski F-Score
4/9
Beneish M-Score
-2.47
Unlikely Manipulator
Ohlson O-Score
-8.37
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
A+
Score: 79.7/100
Trend: Deteriorating
Earnings Quality
OCF/NI: -2.87x
Accruals: -8.0%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. SUPN scores 5.74, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. SUPN scores 4/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. SUPN's score of -2.47 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. SUPN's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. SUPN receives an estimated rating of A+ (score: 79.7/100), with a deteriorating trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-95.78x
PEG
0.98x
P/S
3.60x
P/B
2.58x
P/FCF
36.23x
P/OCF
35.79x
EV/EBITDA
64.15x
EV/Revenue
3.49x
EV/EBIT
-52.56x
EV/FCF
32.98x
Earnings Yield
-0.97%
FCF Yield
2.76%
Shareholder Yield
0.00%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. SUPN currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.590
NI / EBT
×
Interest Burden
0.953
EBT / EBIT
×
EBIT Margin
-0.066
EBIT / Rev
×
Asset Turnover
0.551
Rev / Assets
×
Equity Multiplier
1.345
Assets / Equity
=
ROE
-2.8%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. SUPN's ROE of -2.8% is driven by Asset Turnover (0.551), indicating efficient use of assets to generate revenue. A tax burden ratio of 0.59 suggests the company retains less than 60% of pre-tax earnings after taxes.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$48.21
Median 1Y
$46.10
5th Pctile
$23.19
95th Pctile
$92.45
Ann. Volatility
43.0%
Analyst Target
$65.00
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Jack A. Khattar
Chief Executive Officer, President & Secretary
$1,036,000 $6,535,029 $15,501,557
Timothy C. Dec
Senior Vice President, Chief Financial Officer
$504,900 $315,040 $1,916,409
Jonathan Rubin, MD
Senior Vice President, Chief Medical Officer Research and Development
$485,100 $315,040 $1,448,731
Padmanabh P. Bhatt,
Ph.D. Senior Vice President, Intellectual Property, Chief Scientific Officer
$455,900 $315,040 $1,391,429
Frank Mottola President,
e President, Chief Technical Operations Officer
$412,500 $315,040 $1,360,701

CEO Pay Ratio

25:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $15,501,557
Avg Employee Cost (SGA/emp): $624,117
Employees: 778

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
778
+15.4% YoY
Revenue / Employee
$924,103
Rev: $718,952,000
Profit / Employee
$-49,550
NI: $-38,550,000
SGA / Employee
$624,117
Avg labor cost proxy
R&D / Employee
$136,549
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE 14.9% 12.2% 6.8% 9.4% 7.4% 4.8% 7.1% 6.1% 5.1% 3.0% 0.1% -1.7% 0.6% 6.6% 7.5% 6.3% 6.6% -2.0% -3.7% -2.8% -2.77%
ROA 7.5% 6.1% 3.3% 4.6% 3.6% 2.4% 3.6% 3.1% 2.6% 1.5% 0.1% -1.0% 0.4% 4.0% 5.6% 4.7% 4.9% -1.4% -2.7% -2.1% -2.06%
ROIC 14.8% 12.3% 7.0% 7.9% 5.8% 2.7% 5.3% 5.4% 3.8% 2.4% -0.4% -1.5% 0.5% 6.9% 10.0% 8.2% 8.2% -4.7% -4.4% -4.1% -4.15%
ROCE 12.6% 10.7% 7.0% 7.0% 5.3% 2.8% 6.7% 6.1% 3.2% 4.0% 0.5% -1.0% 2.5% 6.1% 7.9% 8.1% 7.5% -2.0% -4.2% -4.6% -4.63%
Gross Margin 82.3% 87.8% 89.3% 88.2% 88.0% 85.4% 86.3% 84.7% 84.4% 87.3% 88.1% 88.6% 89.4% 90.0% 85.0% 89.5% 89.8% 74.8% 89.1% 88.7% 88.74%
Operating Margin 24.1% 22.0% 3.8% 1.3% 6.7% -0.9% 20.5% 3.4% -13.0% 5.3% -0.6% -2.2% 13.4% 23.2% 12.3% -6.8% 7.3% -31.4% 6.5% -3.6% -3.58%
Net Margin 16.8% 14.5% 1.5% 16.8% 4.6% 1.0% 15.2% 11.0% -0.6% -10.4% 0.7% 0.1% 11.8% 21.9% 8.8% -7.9% 13.6% -23.5% -1.9% -1.1% -1.10%
EBITDA Margin 30.7% 28.0% 13.0% 24.9% 20.4% 13.0% 34.4% 20.2% 3.3% 20.6% 13.8% 11.5% 23.1% 37.0% 26.0% 11.9% 20.2% -19.1% 12.6% 9.0% 9.00%
FCF Margin 20.7% 19.2% 21.7% 15.7% 19.0% 20.9% 17.6% 24.3% 11.3% 15.4% 18.2% 16.7% 24.5% 26.4% 25.9% 24.5% 27.9% 10.4% 6.4% 10.6% 10.59%
OCF Margin 21.0% 19.5% 21.9% 15.8% 19.1% 20.9% 17.5% 24.2% 11.3% 15.3% 18.3% 16.8% 24.6% 26.5% 26.0% 24.6% 28.1% 10.5% 6.6% 10.7% 10.72%
ROE 3Y Avg snapshot only 0.52%
ROE 5Y Avg snapshot only 3.28%
ROA 3Y Avg snapshot only 0.44%
ROIC 3Y Avg snapshot only 0.36%
ROIC Economic snapshot only -3.03%
Cash ROA snapshot only 5.73%
Cash ROIC snapshot only 10.49%
CROIC snapshot only 10.36%
NOPAT Margin snapshot only -4.24%
Pretax Margin snapshot only -6.33%
R&D / Revenue snapshot only 15.29%
SGA / Revenue snapshot only 67.04%
SBC / Revenue snapshot only 7.32%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio 16.82 17.73 29.76 27.06 30.89 49.45 36.48 43.48 37.80 58.76 1210.77 -122.35 284.52 29.25 27.64 29.55 27.68 -141.37 -73.93 -102.70 -95.781
P/S Ratio 2.95 2.57 2.74 3.30 2.82 2.83 3.32 3.38 2.58 2.47 2.62 3.18 2.37 2.68 3.09 2.74 2.68 3.97 3.96 3.84 3.602
P/B Ratio 2.26 1.95 1.95 2.43 2.18 2.28 2.50 2.55 1.85 1.70 1.73 2.06 1.62 1.90 1.97 1.77 1.72 2.61 2.68 2.81 2.581
P/FCF 14.26 13.35 12.67 21.05 14.83 13.54 18.89 13.91 22.78 16.02 14.42 19.00 9.65 10.15 11.92 11.20 9.61 38.20 61.97 36.23 36.231
P/OCF 14.04 13.14 12.51 20.84 14.79 13.50 18.96 14.00 22.86 16.07 14.34 18.91 9.63 10.12 11.87 11.15 9.54 37.60 60.21 35.79 35.791
EV/EBITDA 9.07 9.02 12.98 14.43 13.80 16.75 14.33 15.34 13.95 11.92 15.33 22.33 11.63 10.71 9.79 8.44 8.46 38.11 62.43 64.15 64.149
EV/Revenue 2.94 2.55 2.89 3.45 2.96 2.96 3.29 3.36 2.56 2.44 2.27 2.82 2.03 2.35 2.45 2.11 2.05 3.35 3.59 3.49 3.491
EV/EBIT 10.59 10.72 17.36 21.53 25.64 49.93 32.41 36.42 50.18 36.38 266.21 -175.68 51.41 25.60 19.02 16.22 16.89 -103.66 -55.23 -52.56 -52.562
EV/FCF 14.20 13.28 13.36 21.97 15.56 14.18 18.74 13.81 22.55 15.85 12.49 16.87 8.27 8.91 9.48 8.63 7.35 32.27 56.15 32.98 32.976
Earnings Yield 5.9% 5.6% 3.4% 3.7% 3.2% 2.0% 2.7% 2.3% 2.6% 1.7% 0.1% -0.8% 0.4% 3.4% 3.6% 3.4% 3.6% -0.7% -1.4% -1.0% -0.97%
FCF Yield 7.0% 7.5% 7.9% 4.8% 6.7% 7.4% 5.3% 7.2% 4.4% 6.2% 6.9% 5.3% 10.4% 9.8% 8.4% 8.9% 10.4% 2.6% 1.6% 2.8% 2.76%
PEG Ratio snapshot only 0.979
Price/Tangible Book snapshot only 8.111
EV/OCF snapshot only 32.576
EV/Gross Profit snapshot only 4.077
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 2.57 2.57 1.91 1.91 1.91 1.91 1.07 1.07 1.07 1.07 1.70 1.70 1.70 1.70 2.35 2.35 2.35 2.35 1.90 1.90 1.905
Quick Ratio 2.37 2.37 1.63 1.63 1.63 1.63 0.93 0.93 0.93 0.93 1.43 1.43 1.43 1.43 2.16 2.16 2.16 2.16 1.66 1.66 1.661
Debt/Equity 0.56 0.56 0.52 0.52 0.52 0.52 0.50 0.50 0.50 0.50 0.05 0.05 0.05 0.05 0.03 0.03 0.03 0.03 0.04 0.04 0.039
Net Debt/Equity -0.01 -0.01 0.11 0.11 0.11 0.11 -0.02 -0.02 -0.02 -0.02 -0.23 -0.23 -0.23 -0.23 -0.40 -0.40 -0.40 -0.40 -0.25 -0.25 -0.252
Debt/Assets 0.28 0.28 0.25 0.25 0.25 0.25 0.26 0.26 0.26 0.26 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.028
Debt/EBITDA 2.24 2.59 3.31 2.97 3.16 3.67 2.90 3.04 3.83 3.56 0.46 0.55 0.38 0.29 0.21 0.21 0.21 0.57 0.99 0.97 0.969
Net Debt/EBITDA -0.04 -0.05 0.68 0.61 0.65 0.75 -0.11 -0.11 -0.14 -0.13 -2.37 -2.83 -1.94 -1.49 -2.53 -2.51 -2.60 -7.00 -6.47 -6.33 -6.332
Interest Coverage 6.67 5.70 4.12 4.99 4.65 3.42 9.59 9.30 5.64 10.21 2.15 -10.53
Equity Multiplier 2.02 2.02 2.07 2.07 2.07 2.07 1.92 1.92 1.92 1.92 1.39 1.39 1.39 1.39 1.32 1.32 1.32 1.32 1.37 1.37 1.368
Cash Ratio snapshot only 0.913
Cash to Debt snapshot only 7.533
FCF to Debt snapshot only 2.007
Defensive Interval snapshot only 256.0 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.43 0.42 0.36 0.38 0.39 0.41 0.39 0.39 0.37 0.36 0.41 0.40 0.42 0.44 0.50 0.50 0.50 0.52 0.51 0.55 0.551
Inventory Turnover 2.13 2.04 1.12 1.16 1.09 1.21 0.98 1.05 1.05 0.98 0.99 0.91 0.87 0.85 1.18 1.17 1.16 1.63 1.52 1.63 1.632
Receivables Turnover 5.00 4.95 4.00 4.15 4.35 4.55 4.24 4.25 4.03 3.88 3.92 3.86 4.07 4.21 4.62 4.67 4.65 4.76 4.36 4.71 4.710
Payables Turnover 9.81 9.41 9.70 10.08 9.49 10.50 8.78 9.33 9.40 8.77 13.40 12.25 11.75 11.42 23.78 23.62 23.29 32.67 28.61 30.71 30.715
DSO 73 74 91 88 84 80 86 86 91 94 93 95 90 87 79 78 79 77 84 77 77.5 days
DIO 171 179 326 314 334 302 371 349 347 372 368 402 420 432 309 311 315 225 240 224 223.6 days
DPO 37 39 38 36 38 35 42 39 39 42 27 30 31 32 15 15 16 11 13 12 11.9 days
Cash Conversion Cycle 207 214 380 366 379 347 416 396 399 424 434 467 478 486 372 373 378 290 311 289 289.2 days
Fixed Asset Turnover snapshot only 73.766
Operating Cycle snapshot only 301.1 days
Cash Velocity snapshot only 2.517
Capital Intensity snapshot only 1.870
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 34.6% 18.2% 11.4% 8.1% 10.4% 16.8% 15.1% 11.2% 0.6% -7.3% -8.9% -10.6% -0.6% 6.8% 8.9% 11.8% 5.5% 4.5% 8.6% 16.3% 16.29%
Net Income -15.2% -36.8% -57.9% -34.0% -42.6% -53.9% 13.6% -29.0% -24.6% -32.0% -97.8% -1.3% -87.9% 1.3% 55.1% 5.0% 11.3% -1.3% -1.5% -1.5% -1.47%
EPS -16.9% -37.4% -58.5% -41.7% -48.9% -54.5% -0.2% -30.2% -15.1% -31.5% -97.6% -1.3% -88.2% 1.3% 53.7% 5.0% 11.1% -1.3% -1.5% -1.5% -1.45%
FCF -33.2% -25.1% -7.0% -42.2% 1.3% 26.8% -6.6% 72.5% -39.9% -31.7% -5.7% -38.6% 1.1% 83.1% 54.9% 63.6% 20.4% -58.9% -73.1% -49.6% -49.65%
EBITDA 1.4% -23.0% -38.6% -27.3% -27.0% -27.1% 18.7% 2.0% -13.9% 7.3% -41.3% -48.5% -5.5% 14.6% 84.0% 1.2% 47.1% -58.1% -75.0% -74.7% -74.68%
Op. Income -5.6% -28.3% -50.5% -52.6% -64.5% -85.4% -46.4% -34.0% -60.8% 68.1% -1.1% -1.3% 30.2% 97.1% 16.5% 6.5% 1.4% -1.6% -1.5% -1.6% -1.56%
OCF Growth snapshot only -49.28%
Asset Growth snapshot only 6.18%
Equity Growth snapshot only 2.51%
Debt Growth snapshot only 19.57%
Shares Change snapshot only 3.19%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 16.7% 13.9% 12.3% 14.2% 15.5% 17.3% 19.3% 18.4% 14.3% 8.6% 5.3% 2.4% 3.3% 4.9% 4.5% 3.6% 1.8% 1.1% 2.5% 5.1% 5.13%
Revenue 5Y 26.7% 23.9% 22.2% 21.5% 20.1% 19.0% 17.2% 14.8% 12.1% 9.9% 8.2% 8.1% 9.0% 9.8% 11.0% 10.7% 9.4% 7.4% 6.7% 6.9% 6.90%
EPS 3Y 4.6% -6.2% -21.8% -14.4% -21.7% -29.7% -22.6% -27.3% -28.8% -42.0% -78.4% -62.8% -10.9% 10.1% -2.5% 6.7%
EPS 5Y 29.6% -1.4% -11.0% -8.2% -13.7% -8.7% -1.8% -9.4% -13.0% -23.8% -59.0% -45.5% -11.5% -9.1% -12.6% -12.4%
Net Income 3Y 4.9% -6.1% -21.6% -10.7% -18.2% -29.1% -18.7% -23.5% -28.4% -41.7% -78.2% -62.6% -9.9% 11.4% -5.5% 3.9%
Net Income 5Y 31.1% -0.5% -10.1% -5.4% -11.1% -8.3% 1.2% -6.6% -12.9% -23.7% -58.8% -45.1% -10.8% -8.2% -11.8% -11.4%
EBITDA 3Y 11.5% 3.1% -7.9% -4.4% -8.5% -13.3% -3.6% -6.0% -13.9% -15.6% -24.7% -27.5% -15.9% -3.6% 8.7% 5.2% 6.2% -19.9% -35.4% -33.9% -33.91%
EBITDA 5Y 41.4% 27.3% 17.9% 16.4% 10.4% 5.6% 7.3% 3.5% -2.7% -3.1% -11.5% -14.4% -9.0% -4.3% -0.7% -1.1% -2.4% -22.0% -27.8% -26.5% -26.54%
Gross Profit 3Y 12.7% 10.0% 8.6% 10.5% 12.3% 13.8% 15.5% 14.3% 10.3% 6.0% 3.8% 1.8% 4.3% 6.0% 5.0% 4.1% 1.9% -0.2% 2.0% 4.9% 4.94%
Gross Profit 5Y 24.4% 21.8% 20.3% 19.6% 18.5% 17.2% 15.1% 12.5% 9.5% 7.4% 5.9% 6.1% 7.2% 8.2% 9.2% 8.9% 7.9% 5.5% 5.6% 6.2% 6.17%
Op. Income 3Y 5.8% -4.0% -15.9% -18.6% -29.0% -50.5% -32.3% -31.3% -49.1% -44.0% -43.4% -21.6% -1.7% -0.1% 7.2%
Op. Income 5Y 40.3% 23.7% 10.6% 3.4% -8.0% -26.2% -14.3% -15.4% -30.3% -26.4% -28.8% -16.7% -11.3% -13.3% -16.2%
FCF 3Y 3.3% -6.1% -0.7% -11.1% -8.5% 1.5% -5.8% 12.6% -25.9% -13.5% -6.4% -15.1% 9.3% 16.6% 10.9% 20.1% 15.8% -19.9% -26.8% -20.3% -20.33%
FCF 5Y 33.0% 12.7% 14.0% 2.9% 5.7% 6.2% 0.8% 5.2% -7.7% -6.4% -2.9% -5.7% -0.3% 5.5% 4.1% 7.5% 1.0% -13.4% -19.4% -12.8% -12.81%
OCF 3Y 3.2% -5.9% -0.5% -10.9% -8.5% 1.5% -6.5% 10.7% -26.7% -14.6% -7.1% -15.4% 8.9% 16.1% 10.6% 19.9% 15.9% -19.5% -26.0% -19.8% -19.84%
OCF 5Y 31.4% 12.3% 13.7% 2.7% 5.4% 6.0% 0.4% 4.7% -8.1% -6.7% -2.9% -5.7% -0.3% 5.5% 3.7% 6.6% 0.5% -13.7% -19.3% -12.9% -12.86%
Assets 3Y 52.5% 52.5% 20.0% 20.0% 20.0% 20.0% 13.6% 13.6% 13.6% 13.6% -5.3% -5.3% -5.3% -5.3% -6.8% -6.8% -6.8% -6.8% -5.2% -5.2% -5.15%
Assets 5Y 51.5% 51.5% 40.4% 40.4% 40.4% 40.4% 32.0% 32.0% 32.0% 32.0% 5.5% 5.5% 5.5% 5.5% 3.3% 3.3% 3.3% 3.3% -0.7% -0.7% -0.69%
Equity 3Y 40.7% 40.7% 21.7% 21.7% 21.7% 21.7% 14.2% 14.2% 14.2% 14.2% 7.4% 7.4% 7.4% 7.4% 8.3% 8.3% 8.3% 8.3% 6.2% 6.2% 6.21%
Book Value 3Y 40.2% 40.6% 21.3% 16.6% 16.5% 20.8% 8.7% 8.5% 13.6% 13.6% 6.5% 6.4% 6.7% 6.3% 7.0% 11.7% 11.2% 7.3% 9.1% 9.1% 9.08%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.95 0.98 0.95 0.95 0.97 0.99 0.97 0.95 0.91 0.88 0.84 0.75 0.82 0.80 0.77 0.72 0.76 0.74 0.76 0.69 0.692
Earnings Stability 0.49 0.22 0.00 0.00 0.20 0.04 0.05 0.18 0.48 0.66 0.75 0.77 0.88 0.61 0.45 0.56 0.56 0.75 0.58 0.63 0.630
Margin Stability 0.96 0.96 0.96 0.95 0.95 0.95 0.95 0.95 0.94 0.95 0.95 0.95 0.95 0.95 0.96 0.96 0.96 0.97 0.98 0.98 0.985
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 0.00 0.00 0.000
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.94 0.85 0.50 0.86 0.83 0.50 0.95 0.88 0.90 0.87 0.50 0.20 0.50 0.50 0.50 0.20 0.50 0.20 0.20 0.20 0.200
Earnings Smoothness 0.84 0.55 0.18 0.59 0.46 0.26 0.87 0.66 0.72 0.62 0.00 0.00 0.20 0.00 0.00
ROE Trend -0.08 -0.12 -0.11 -0.08 -0.10 -0.12 -0.05 -0.06 -0.05 -0.05 -0.07 -0.09 -0.05 0.03 0.04 0.04 0.03 -0.07 -0.07 -0.05 -0.049
Gross Margin Trend -0.09 -0.08 -0.06 -0.05 -0.02 -0.02 -0.02 -0.02 -0.02 -0.01 -0.01 0.01 0.02 0.02 0.02 0.02 0.02 -0.03 -0.02 -0.02 -0.022
FCF Margin Trend -0.19 -0.12 -0.09 -0.13 -0.12 -0.04 -0.06 0.02 -0.08 -0.05 -0.01 -0.03 0.09 0.08 0.08 0.04 0.10 -0.11 -0.16 -0.10 -0.100
Sustainable Growth Rate 14.9% 12.2% 6.8% 9.4% 7.4% 4.8% 7.1% 6.1% 5.1% 3.0% 0.1% 0.6% 6.6% 7.5% 6.3% 6.6%
Internal Growth Rate 8.1% 6.5% 3.5% 4.8% 3.7% 2.4% 3.7% 3.2% 2.6% 1.5% 0.1% 0.4% 4.2% 5.9% 4.9% 5.1%
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 1.20 1.35 2.38 1.30 2.09 3.66 1.92 3.11 1.65 3.66 84.41 -6.47 29.56 2.89 2.33 2.65 2.90 -3.76 -1.23 -2.87 -2.869
FCF/OCF 0.98 0.98 0.99 0.99 1.00 1.00 1.00 1.01 1.00 1.00 1.00 0.99 1.00 1.00 1.00 1.00 0.99 0.98 0.97 0.99 0.988
FCF/Net Income snapshot only -2.834
OCF/EBITDA snapshot only 1.969
CapEx/Revenue 0.3% 0.3% 0.3% 0.2% 0.1% 0.1% 0.1% 0.2% 0.0% 0.0% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.2% 0.2% 0.2% 0.1% 0.13%
CapEx/Depreciation snapshot only 0.011
Accruals Ratio -0.01 -0.02 -0.05 -0.01 -0.04 -0.06 -0.03 -0.06 -0.02 -0.04 -0.07 -0.08 -0.10 -0.08 -0.07 -0.08 -0.09 -0.07 -0.06 -0.08 -0.080
Sloan Accruals snapshot only -0.129
Cash Flow Adequacy snapshot only 82.350
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
FCF Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Total Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -0.5% -0.6% -0.4% -0.3% -0.3% -0.6% -0.6% -0.6% -0.9% -0.6% -0.5% -0.5% -0.6% -0.6% -0.7% -0.8% -0.9% -1.3% -1.3% -1.7% -1.65%
Total Shareholder Return -0.5% -0.6% -0.4% -0.3% -0.3% -0.6% -0.6% -0.6% -0.9% -0.6% -0.5% -0.5% -0.6% -0.6% -0.7% -0.8% -0.9% -1.3% -1.3% -1.7% -1.65%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 0.74 0.74 0.73 0.95 1.01 1.36 1.00 0.95 1.63 0.69 0.48 2.58 0.14 0.82 0.75 0.67 0.78 0.92 0.79 0.59 0.590
Interest Burden (EBT/EBIT) 0.85 0.82 0.76 0.80 0.79 0.71 0.90 0.89 0.82 0.90 0.53 0.63 1.51 1.21 1.15 1.06 1.02 0.94 1.05 0.95 0.953
EBIT Margin 0.28 0.24 0.17 0.16 0.12 0.06 0.10 0.09 0.05 0.07 0.01 -0.02 0.04 0.09 0.13 0.13 0.12 -0.03 -0.07 -0.07 -0.066
Asset Turnover 0.43 0.42 0.36 0.38 0.39 0.41 0.39 0.39 0.37 0.36 0.41 0.40 0.42 0.44 0.50 0.50 0.50 0.52 0.51 0.55 0.551
Equity Multiplier 1.99 1.99 2.05 2.05 2.05 2.05 1.99 1.99 1.99 1.99 1.65 1.65 1.65 1.65 1.35 1.35 1.35 1.35 1.34 1.34 1.345
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $1.83 $1.50 $0.98 $1.19 $0.94 $0.68 $0.98 $0.83 $0.80 $0.47 $0.02 $-0.28 $0.09 $1.07 $1.31 $1.11 $1.14 $-0.34 $-0.67 $-0.50 $-0.50
Book Value/Share $13.61 $13.71 $14.96 $13.29 $13.29 $14.82 $14.27 $14.19 $16.26 $16.23 $16.74 $16.57 $16.54 $16.45 $18.34 $18.54 $18.29 $18.31 $18.51 $18.42 $18.68
Tangible Book/Share $5.53 $5.57 $-1.58 $-1.41 $-1.41 $-1.57 $1.07 $1.07 $1.22 $1.22 $3.72 $3.68 $3.67 $3.65 $7.03 $7.10 $7.01 $7.02 $6.41 $6.37 $6.37
Revenue/Share $10.43 $10.39 $10.63 $9.79 $10.26 $11.97 $10.75 $10.70 $11.63 $11.18 $11.03 $10.74 $11.31 $11.64 $11.72 $11.96 $11.74 $12.05 $12.54 $13.48 $13.48
FCF/Share $2.16 $2.00 $2.30 $1.54 $1.95 $2.50 $1.89 $2.60 $1.32 $1.72 $2.01 $1.79 $2.77 $3.07 $3.03 $2.92 $3.28 $1.25 $0.80 $1.43 $1.43
OCF/Share $2.19 $2.03 $2.33 $1.55 $1.96 $2.51 $1.88 $2.59 $1.31 $1.72 $2.02 $1.80 $2.78 $3.08 $3.05 $2.94 $3.30 $1.27 $0.83 $1.44 $1.44
Cash/Share $7.72 $7.78 $6.23 $5.53 $5.53 $6.17 $7.43 $7.39 $8.46 $8.45 $4.63 $4.58 $4.57 $4.55 $8.03 $8.12 $8.01 $8.02 $5.38 $5.35 $6.67
EBITDA/Share $3.38 $2.94 $2.37 $2.34 $2.20 $2.12 $2.47 $2.34 $2.13 $2.29 $1.64 $1.36 $1.97 $2.56 $2.93 $2.99 $2.85 $1.06 $0.72 $0.73 $0.73
Debt/Share $7.57 $7.63 $7.83 $6.95 $6.96 $7.76 $7.16 $7.12 $8.16 $8.14 $0.75 $0.75 $0.75 $0.74 $0.61 $0.61 $0.61 $0.61 $0.71 $0.71 $0.71
Net Debt/Share $-0.15 $-0.15 $1.60 $1.42 $1.42 $1.59 $-0.27 $-0.27 $-0.30 $-0.30 $-3.87 $-3.84 $-3.83 $-3.81 $-7.43 $-7.51 $-7.40 $-7.42 $-4.67 $-4.64 $-4.64
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 5.743
Altman Z-Prime snapshot only 10.309
Piotroski F-Score 5 6 6 5 6 5 6 5 6 6 7 6 6 7 7 8 8 5 5 4 4
Beneish M-Score -1.95 -1.99 -2.66 -2.43 -2.56 -2.64 -2.51 -2.69 -2.41 -2.56 -3.11 -3.14 -3.16 -3.03 -2.85 -2.90 -2.99 -2.98 -2.49 -2.47 -2.468
Ohlson O-Score snapshot only -8.366
ROIC (Greenblatt) snapshot only -16.30%
Net-Net WC snapshot only $4.39
EVA snapshot only $-112352210.00
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only A+
Credit Score 69.90 65.66 56.13 58.03 57.36 59.30 67.78 69.31 55.82 61.70 77.72 71.21 89.53 92.46 92.65 92.49 92.23 79.14 80.12 79.66 79.656
Credit Grade snapshot only 5
Credit Trend snapshot only -12.835
Implied Spread (bps) snapshot only 125.000
Industry Credit Rank snapshot only 69
Sector Credit Rank snapshot only 78

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms